Calendar Cullinan Therapeutics, Inc.

Equities

CGEM

US2300311063

Market Closed - Nasdaq 21:00:00 19/07/2024 BST 5-day change 1st Jan Change
18.29 USD -0.54% Intraday chart for Cullinan Therapeutics, Inc. +11.19% +79.49%

Chart calendar Cullinan Therapeutics, Inc.

a2ed58600fb8cbe8.78JqKejjWjObl-L1J36Zqm57T4lKhIFz7KhKehVVfS8.mIo6YqquKkLu0LjFCkr9mScCfNsk1eA1lM15PHE-CB6-qBlCsJUPa9fhrw~cc3ce2f1bb82b9190cdc9524de387ad7

Upcoming events on Cullinan Therapeutics, Inc.

07/08/2024 Q2 2024 Earnings Release (Projected)
10/11/2024 Q3 2024 Earnings Release (Projected)
05/03/2025 Q4 2024 Earnings Release (Projected)
19/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Cullinan Therapeutics, Inc.

26/06/2024 15:00 Annual General Meeting
01/06/2024 15:00 American Society of Clinical Oncology Meeting - Poster Number: 2588
29/05/2024 16:30 TD Cowen Oncology Innovation Summit
15/05/2024 21:05 Q1 2024 Earnings Release
16/04/2024 13:00 Business Update Call
14/03/2024 11:00 Q4 2023 Earnings Release
13/03/2024 12:00 Leerink Partners Global Biopharma Conference - Fireside Chat
05/03/2024 15:30 TD Cowen Health Care Conference - Panel
11/01/2024 18:30 JPMorgan Healthcare Conference
30/11/2023 13:20 Evercore ISI HealthCONx Conference
14/11/2023 20:35 Stifel Healthcare Conference
08/11/2023 12:00 Q3 2023 Earnings Release
04/11/2023 16:00 Society for Immunotherapy of Cancer Meeting - Poster Number: 1024
04/11/2023 16:00 Society for Immunotherapy of Cancer Meeting - Poster Number: 194
03/11/2023 17:30 TD Cowen Fall Oncology Innovation Summit
03/11/2023 16:00 Society for Immunotherapy of Cancer Meeting - Poster Number: 771
03/11/2023 16:00 Society for Immunotherapy of Cancer Meeting - Poster Number: 1093
03/11/2023 16:00 Society for Immunotherapy of Cancer Meeting - Poster Number: 1171
28/09/2023 14:45 Cantor Global Healthcare Conference
13/09/2023 15:50 Morgan Stanley Global Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


0,00
6,00
-
18,9
18,9
0.08%
0,00
138
-
0,00
0,00
-

1,88

EBITDA
Million USD
Released
Forecast
Spread
0,00


-60,3
-43,9
-37.16%
-67,9
-58,0
-17.09%
145
145
-0.24%
-190
-192
0.78%

-169

EBIT
Million USD
Released
Forecast
Spread
-22,3


-60,3
-44,0
-37.07%
-68,0
-55,6
-22.2%
145
145
-0.32%
-191
-192
0.81%

-184

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-59,5
-46,9
-26.78%
0,00
0,00
-
151
148
2.16%
-169
-170
0.72%

-161

Net income
Million USD
Released
Forecast
Spread
0,00


-51,8
-34,9
-48.41%
-65,6
-52,9
-23.93%
111
107
3.95%
-153
-170
10.08%

-165

EPS
USD
Released
Forecast
Spread
-1 127


-3,64
-2,99
-21.84%
-1,52
-1,26
-20.32%
2,38
2,33
2.15%
-3,69
-4,08
9.47%

-3,01

Announcement Date02/11/2030/03/2117/03/2209/03/2314/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
275
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-32,7
-24,9
-31.09%
240
241
-0.73%
-29,8
-36,1
17.59%
-32,6
-32,1
-1.57%
-62,8
-59,2
-5.94%
-37,6
-36,9
-2.04%
-45,2
-41,7
-8.54%
-45,5
-47,1
3.52%
-43,0
-47,0
8.59%

-45,1


-47,7


-50,0


-59,0


-62,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread



240
242
-0.62%
-27,4
-35,0
21.69%
-28,9
-30,8
6.09%
-58,1
-56,2
-3.47%
-32,2
-35,5
9.13%
-39,2
-39,8
1.62%
-39,7
-41,6
4.62%
-37,3
-43,4
13.88%

-40,3


-42,5


-44,0


-59,0


-61,5

Net income
Million USD
Released
Forecast
Spread
-12,1
-24,6
50.9%
175
243
-28%
-24,8
-51,5
51.79%
-26,8
-32,1
16.52%
-58,0
-42,1
-37.69%
-32,2
-41,8
22.86%
-39,2
-39,5
0.79%
-23,8
-41,6
42.79%
-37,1
-42,9
13.37%

-40,6


-43,6


-46,2


-59,0


-62,0

EPS
USD
Released
Forecast
Spread
-0,27
-0,55
50.91%
3,77
5,42
-30.4%
-0,54
-0,97
44.14%
-0,59
-0,67
11.28%
-1,42
-0,98
-44.9%
-0,82
-0,97
15.46%
-0,91
-0,94
2.99%
-0,54
-0,96
43.6%
-0,86
-0,92
6.52%

-0,72


-0,73


-0,74


-0,86


-0,89

Announcement Date16/05/2210/08/2214/11/2209/03/2311/05/2310/08/2308/11/2314/03/2415/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CGEM Stock
  4. Calendar Cullinan Therapeutics, Inc.